A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 9, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMRC SEC filings page.
This page shows Ameresco, Inc. (AMRC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Ameresco's project-financed business has improved cash conversion, while leverage remains central and FY2025 earnings include a large tax benefit.
Profits did not translate into cash in FY2021: net income was$70.5M while operating cash flow was-$172.3M , pointing to heavy cash absorption in operations. By FY2024, operating cash flow reached$117.6M and free cash flow reached$113.3M , showing that cash conversion can swing materially even when reported profitability is modest.
From FY2023 to FY2024, revenue rose
From FY2022 to FY2025, long-term debt increased
Financial Health Signals
We do not publish a peer-relative financial health score for Ameresco, Inc., because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
Ameresco, Inc. generated $580.3M in revenue in Q3 2026. This represents an increase of 10.3% from the same quarter a year earlier. Against the prior quarter it is up 12.6%.
Ameresco, Inc.'s EBITDA was $87.2M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 25.4% from the same quarter a year earlier. Against the prior quarter it is up 17.4%.
Ameresco, Inc. reported $31.9M in net income in Q3 2026. This represents a decrease of 56.9% from the same quarter a year earlier. Against the prior quarter it is up 336.9%.
Ameresco, Inc. earned $0.59 per diluted share (EPS) in Q3 2026. This represents a decrease of 57.6% from the same quarter a year earlier. Against the prior quarter it is up 321.4%.
Cash & Balance Sheet
Ameresco, Inc. recorded an outflow of $9.5M in free cash flow in Q3 2026, representing a cash shortfall after capex. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Ameresco, Inc. held $128.5M in cash against $1.8B in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Ameresco, Inc.'s gross margin was 18.7% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 3.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.0 percentage points.
Ameresco, Inc.'s operating margin was 10.6% in Q3 2026, reflecting core business profitability. This is up 2.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.0 percentage points.
Ameresco, Inc.'s net profit margin was 5.5% in Q3 2026, showing the share of revenue converted to profit. This is down 8.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.1 percentage points.
Ameresco, Inc.'s quarterly ROE was 2.5% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 4.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.0 percentage points.
Capital Allocation
Ameresco, Inc. invested $648K in capex in Q3 2026, funding long-term assets and infrastructure. Against the prior quarter it is down 24.8%.
Not reported for Q3 2026.
Not reported for Q3 2026.
AMRC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $580.3M+10.3% | $515.5M+9.1% | $401.5M+13.8% | N/A | $526.0M+5.0% | $472.3M+7.8% | $352.8M+18.2% | $532.7M+20.7% |
| Cost of Revenue | $471.7M+6.3% | $427.0M+6.5% | $347.8M+14.8% | $489.3M+5.0% | $443.7M+4.7% | $401.0M+7.5% | $302.9M+20.5% | $465.9M+26.9% |
| Gross Profit | $108.6M+32.0% | $91.3M+24.5% | $56.5M+8.8% | N/A | $82.3M+6.7% | $73.4M+12.6% | $51.9M+10.5% | $66.8M-10.0% |
| SG&A Expenses | $47.6M+9.7% | $47.5M+4.0% | $46.3M+20.3% | N/A | $43.4M+2.9% | $45.7M+3.4% | $38.5M-2.7% | $47.8M+30.5% |
| Operating Income | $61.3M+51.9% | $44.1M+59.0% | $10.2M-25.2% | N/A | $40.3M+14.7% | $27.8M+32.6% | $13.7M+71.3% | $44.6M+31.0% |
| EBITDA | $87.2M+25.4% | $74.3M+40.2% | $39.5M+5.0% | N/A | $69.6M+18.7% | $53.0M+28.2% | $37.6M+40.3% | $71.2M+32.0% |
| Interest Expense | $25.9M+17.6% | $26.4M+24.0% | $25.2M+26.5% | N/A | $22.1M+19.8% | $21.3M+43.7% | $19.9M+39.8% | $17.6M+431.2% |
| Income Tax | -$12.3Mn/m | -$206Kn/m | -$3.9M-115.6% | -$71.5Mn/m | -$61.1Mn/m | -$42.2Mn/m | $25.3Mn/m | -$16.7Mn/m |
| Net Income | $31.9M-56.9% | $7.3M-85.5% | -$20.3Mn/m | $80.9M+118.3% | $74.0M+320.7% | $50.2M+901.8% | -$31.5Mn/m | $37.1M+9.9% |
| EPS (Basic) | $0.60-57.1% | $0.14-85.3% | -$0.39n/m | $1.50+111.3% | $1.40+311.8% | $0.95+850.0% | -$0.60n/m | $0.71+9.2% |
| EPS (Diluted) | $0.59-57.6% | $0.14-85.3% | -$0.39n/m | $1.51+115.7% | $1.39+321.2% | $0.95+955.6% | -$0.60n/m | $0.70+11.1% |
| Diluted Shares (Avg) | 54M+0.6% | 54M+1.9% | 53M+0.7% | N/A | 53M+0.2% | 53M-0.5% | 53M+0.5% | N/A |
Not reported in any period shown, so not listed: R&D Expenses.
AMRC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.3B+18.7% | $4.8B+12.5% | $4.6B+11.3% | $4.7B+13.6% | $4.4B+11.2% | $4.3B+8.3% | $4.2B+9.6% | $4.2B+12.0% |
| Current Assets | $1.8B+26.4% | $1.7B+31.2% | $1.6B+23.7% | $1.6B+20.9% | $1.4B+16.0% | $1.3B+3.3% | $1.3B+11.6% | $1.3B+15.3% |
| Cash & Equivalents | $128.5M+35.9% | $138.3M+69.5% | $104.0M+45.2% | $71.8M-33.8% | $94.6M-16.7% | $81.6M-45.7% | $71.6M-7.8% | $108.5M+36.9% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | $12.0M-5.9% | $12.6M+2.0% | $12.5M+1.4% | $12.6M+9.1% | $12.8M+6.8% | $12.4M-0.8% | $12.3M-5.6% | $11.6M-15.3% |
| Accounts Receivable | $276.6M+9.0% | $252.6M+2.7% | $249.2M+9.9% | $257.9M+0.3% | $253.8M+10.2% | $245.9M+59.0% | $226.7M+54.4% | $257.0M+67.6% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $68.9M-0.6% | $68.9M-0.8% | $69.0M+1.0% | $69.3M+4.5% | $69.2M-8.8% | $69.4M-7.7% | $68.3M-9.3% | $66.3M-12.3% |
| Total Liabilities | $4.0B+18.7% | $3.6B+10.3% | $3.6B+13.3% | $3.5B+9.9% | $3.4B+10.7% | $3.3B+6.9% | $3.2B+9.0% | $3.1B+11.9% |
| Current Liabilities | $1.1B+15.7% | $1.0B+22.2% | $1.0B+30.8% | $1.0B+15.7% | $939.3M-2.6% | $822.1M-33.3% | $798.3M-31.3% | $889.0M-1.4% |
| Non-Current Liabilities | $2.9B+19.9% | $2.6B+6.2% | $2.5B+7.3% | $2.4B+7.6% | $2.4B+16.9% | $2.4B+34.1% | $2.4B+35.9% | $2.3B+18.1% |
| Long-Term Debt | $1.8B+6.8% | $1.8B+8.0% | $1.8B+16.4% | $1.7B+17.9% | $1.7B+30.3% | $1.7B+54.0% | $1.6B+55.0% | $1.5B+26.8% |
| Total Equity | $1.3B+18.5% | $1.2B+19.5% | $1.1B+5.2% | $1.3B+25.2% | $1.1B+12.6% | $1.0B+13.1% | $1.0B+11.8% | $1.0B+12.3% |
| Retained Earnings | $903.6M+33.2% | $688.1M+4.3% | $864.4M+33.6% | $884.7M+35.6% | $678.4M+10.2% | $659.9M+10.4% | $647.1M+9.1% | $652.6M+9.5% |
AMRC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$8.8M-150.0% | -$86.8M-297.7% | $35.4Mn/m | N/A | $17.7M-29.4% | $43.9M-17.6% | -$28.3M-236.0% | $18.4Mn/m |
| Depreciation & Amortization | $26.0M-11.3% | $30.1M+19.6% | $29.3M+22.2% | N/A | $29.3M+24.8% | $25.2M+23.7% | $23.9M+27.1% | $26.5M+33.7% |
| Stock-Based Compensation | $4.1M+9.2% | $3.4M-9.9% | $4.2M+46.8% | N/A | $3.7M+2.2% | $3.8M+2.0% | $2.8M-6.0% | N/A |
| Capital Expenditures | $648K | $862K+486.4% | $542K+28.4% | N/A | N/A | $147K-86.7% | $422K-56.1% | $1.2M+10.9% |
| Free Cash Flow | -$9.5M | -$87.7M-300.3% | $34.9Mn/m | N/A | N/A | $43.8M-16.2% | -$28.7M-244.7% | $17.1Mn/m |
| Investing Cash Flow | -$148.4Mn/m | -$113.3Mn/m | -$96.9Mn/m | N/A | -$153.0Mn/m | -$57.7Mn/m | -$118.4Mn/m | -$31.2Mn/m |
| Financing Cash Flow | $127.0M+42.7% | $218.7M+103.7% | $128.5M+12.2% | N/A | $89.0M+33.6% | $107.4M-33.3% | $114.5M+48.0% | $8.9M-91.8% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
AMRC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 18.7%+3.1pp | 17.7%+2.2pp | 14.1%-0.7pp | N/A | 15.7%+0.3pp | 15.5%+0.7pp | 14.7%-1.0pp | 12.5%-4.3pp |
| Operating Margin | 10.6%+2.9pp | 8.6%+2.7pp | 2.5%-1.3pp | N/A | 7.7%+0.7pp | 5.9%+1.1pp | 3.9%+1.2pp | 8.4%+0.7pp |
| Net Margin | 5.5%-8.6pp | 1.4%-9.2pp | -5.1%+3.9pp | N/A | 14.1%+10.6pp | 10.6%+9.5pp | -8.9%-8.0pp | 7.0%-0.7pp |
| Return on Equity | 2.5%-4.5pp | 0.6%-4.3pp | -1.9%+1.2pp | 6.4%+2.7pp | 7.0%+5.1pp | 4.9%+4.3pp | -3.1%-2.8pp | 3.7%-0.1pp |
| Return on Assets | 0.6%-1.1pp | 0.1%-1.0pp | -0.4%+0.3pp | 1.7%+0.8pp | 1.7%+1.2pp | 1.2%+1.0pp | -0.8%-0.7pp | 0.9%0.0pp |
| Current Ratio | 1.65+0.1x | 1.67+0.1x | 1.49-0.1x | 1.53+0.1x | 1.51+0.2x | 1.56+0.6x | 1.57+0.6x | 1.46+0.2x |
| Debt-to-Equity | 1.47-0.2x | 1.45-0.2x | 1.71+0.2x | 1.38-0.1x | 1.63+0.2x | 1.61+0.4x | 1.55+0.4x | 1.46+0.2x |
| Liabilities-to-Equity | 3.200.0x | 2.91-0.2x | 3.36+0.2x | 2.73-0.4x | 3.19-0.1x | 3.15-0.2x | 3.12-0.1x | 3.100.0x |
| Asset Turnover | 0.110.0x | 0.110.0x | 0.090.0x | N/A | 0.120.0x | 0.110.0x | 0.080.0x | 0.130.0x |
| FCF Margin | -1.6% | -17.0%-26.3pp | 8.7%+16.8pp | N/A | N/A | 9.3%-2.6pp | -8.1%-14.8pp | 3.2%+10.2pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Ameresco, Inc. AMRC | FY2025 | N/A | $173.6M | N/A | $1.2B | — |
| Willdan Group, Inc. WLDN | FY2025 | $681.6M | $52.6M | 7.7% | $1.1B | 61/100 |
| Bowman Consulting Group Ltd. BWMN | FY2025 | $490.0M | $12.8M | 2.6% | N/A | 45/100 |
| Concrete Pumping Holdings, Inc. BBCP | FY2025 | $392.9M | $6.4M | 1.6% | $492.3M | 49/100 |
| Orion Group Holdings, Inc ORN | FY2025 | $852.3M | $2.5M | 0.3% | $286.2M | 44/100 |
| Phoenix Asia Holdings Limited PHOE | FY2026 | $7.2M | -$1.2M | -16.7% | $324.0M | 70/100 |
Where Ameresco, Inc. Ranks
Frequently Asked Questions
Yes, Ameresco, Inc. (AMRC) reported a net income of $99.8M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $173.6M.
As of fiscal year 2025, Ameresco, Inc. (AMRC) had $71.8M in cash and equivalents against $1.7B in long-term debt.
Ameresco, Inc. (AMRC) has a return on equity of 13.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Ameresco, Inc. (AMRC) had $4.7B in total assets as of fiscal year 2025, including both current and long-term assets.
Ameresco, Inc. (AMRC) had a current ratio of 1.53 as of fiscal year 2025, which is generally considered healthy.
Ameresco, Inc. (AMRC) had a debt-to-equity ratio of 1.38 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Ameresco, Inc. (AMRC) had a liabilities-to-equity ratio of 2.73 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Ameresco, Inc. (AMRC) had a return on assets of 3.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Ameresco, Inc. (AMRC) trades at 12.1x earnings, its market capitalization divided by $99.8M net income, trailing 12 months to September 30, 2026. The market capitalization is $1.2B as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Ameresco, Inc. (AMRC) has no price-to-sales ratio at the moment: no full year of revenue reported yet. The market capitalization is $1.2B as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.